4-oxo-1-phenyl-4,5,6,7-tetrahydroisoindole | 202286-29-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: 4-oxo-1-phenyl-4,5,6,7-tetrahydroisoindole
• 英文别名: 1-Phenyl-2,5,6,7-tetrahydroisoindol-4-one
• CAS: 202286-29-1
• 化学式: C₁₄H₁₃NO
• mdl: MFCD13811533
• 分子量: 211.263
• InChiKey: ZQLNLLNDMBWRNR-UHFFFAOYSA-N

物化性质

• 沸点：
  454.5±34.0 °C(Predicted)
• 密度：
  1.197±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  32.9
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4-oxo-1-phenyl-4,5,6,7-tetrahydroisoindole 在 potassium tert-butylate 、 sodium hydride 作用下， 以 四氢呋喃 、 乙醇 、 甲苯 、 mineral oil 为溶剂， 反应 53.0h， 生成 8-methyl-7-phenyl-3,5,6,8-tetrahydro-2H-pyrrolo[3,4-h]quinazolin-2-one
  参考文献：
  名称：

  Synthesis of a new class of pyrrolo[3,4-h]quinazolines with antimitotic activity

  摘要：

  A new series of pyrrolo[3,4-h]quinazolines was conveniently prepared with a broad substitution pattern. A large number of derivatives was obtained and the cellular cytotoxicity was evaluated in vitro against 5 different human tumor cell lines with GI(50) values reaching the low micromolar level (1.3-19.8 mu M). These compounds were able to induce cell death mainly by apoptosis through a mitochondrial dependent pathway. Selected compounds showed antimitotic activity and a reduction of tubulin polymerization in a concentration-dependent manner. Moreover, they showed anti-angiogenic properties since reduced in vitro endothelial cell migration and disrupted HUVEC capillary-like tube network in Matrigel. (C) 2013 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2013.10.014
• 作为产物：
  描述：

  DL-2-(1-carboxy-1-phenylmethylaminomethylene)cyclohexane-1,3-dione 在 盐酸 、 三乙胺 作用下， 反应 0.75h， 生成 4-oxo-1-phenyl-4,5,6,7-tetrahydroisoindole
  参考文献：
  名称：

  A facile route to pyrroles, isoindoles and hetero fused analogues

  摘要：

  从 1,2-二甲氨基亚甲基或 1,2-羟基亚甲基羰基化合物和氨基酸中提取的烯氨酸经过脱羧环化反应生成吡咯、异吲哚和其他融合吡咯。环己烷-1,3-二酮中的烯氨基酸和 α-烷基-α-氨基酸会优先发生双原子扩环，生成氧代氨基[2,3-c]吡咯。

  DOI：

  10.1039/b209255g

文献信息

• [EN] NEW THERAPEUTIC AGENTS FOR THE TREATMENT OF HAEMATOLOGICAL PATHOLOGIES<br/>[FR] NOUVEAUX AGENTS THÉRAPEUTIQUES POUR LE TRAITEMENT DE PATHOLOGIES HÉMATOLOGIQUES
  申请人：UNIV DEGLI STUDI DI PALERMO

  公开号：WO2021038452A1

  公开（公告）日：2021-03-04

  The present invention relates to compounds having a tetracyclic system and the use thereof as new therapeutic agents in the treatment of acute myeloid leukemia (AML), preferably in FLT3/ITD hemizygote patients resistant to conventional therapies. The invention also relates to 5,7-dihydro-4H-[1,3]thiazolo[4,5-e]isoindol-2-amine compounds useful as intermediates for the synthesis of tetracyclic imidazo[2',1':2,3][1,3]thiazolo[4,5-e]isoindole compounds.

  该发明涉及具有四环系统的化合物及其作为新的治疗剂在治疗急性髓样白血病（AML）中的用途，优选用于对传统疗法具有抗药性的FLT3/ITD半合子患者。该发明还涉及5,7-二氢-4H-[1,3]噻唑并[4,5-e]异吲哚-2-胺化合物，可用作合成四环咪唑并[2',1':2,3][1,3]噻唑并[4,5-e]异吲哚化合物的中间体。
• Preclinical Activity of New [1,2]Oxazolo[5,4-<i>e</i>]isoindole Derivatives in Diffuse Malignant Peritoneal Mesothelioma
  作者：Virginia Spanò、Marzia Pennati、Barbara Parrino、Anna Carbone、Alessandra Montalbano、Vincenzo Cilibrasi、Valentina Zuco、Alessia Lopergolo、Denis Cominetti、Patrizia Diana、Girolamo Cirrincione、Paola Barraja、Nadia Zaffaroni

  DOI：10.1021/acs.jmedchem.6b00777

  日期：2016.8.11

  series of 22 derivatives of the [1,2]oxazolo[5,4-e]isoindole system were synthesized through an efficient and versatile procedure that involves the annelation of the [1,2]oxazole moiety to the isoindole ring, producing derivatives with a wide substitution pattern. The structure–activity relationship indicates that the N-4-methoxybenzyl group appears crucial for potent activity. In addition, the presence

  [1,2]恶唑并[5,4- e ]异吲哚体系的一系列22种衍生物是通过一种有效且通用的方法合成的，该方法涉及将[1,2]恶唑部分与异吲哚环进行脱环反应，从而制得衍生物具有广泛的替代模式。结构-活性关系表明Ñ-4-甲氧基苄基似乎对有效活性至关重要。另外，6-苯基部分的存在是重要的，并且用3,4,5-三甲氧基取代基达到最佳活性。当对完整的NCI人肿瘤细胞系进行测试时，具有这两个结构特征的最具活性的化合物能够在纳摩尔浓度下抑制肿瘤细胞的增殖。有趣的是，由于微管蛋白聚合的抑制作用，在弥漫性恶性腹膜间皮瘤（DMPM）（一种快速致死性疾病）的实验模型中，该化合物可有效降低体外和体内细胞生长，削弱细胞周期进程并诱导凋亡。 ，对常规治疗策略的反应较差。
• Insight on [1,3]thiazolo[4,5-e]isoindoles as tubulin polymerization inhibitors
  作者：Virginia Spanò、Marilia Barreca、Roberta Rocca、Roberta Bortolozzi、Ruoli Bai、Anna Carbone、Maria Valeria Raimondi、Antonio Palumbo Piccionello、Alessandra Montalbano、Stefano Alcaro、Ernest Hamel、Giampietro Viola、Paola Barraja

  DOI：10.1016/j.ejmech.2020.113122

  日期：2021.2

  A series of [1,3]thiazolo[4,5-e]isoindoles has been synthesized through a versatile and high yielding multistep sequence. Evaluation of the antiproliferative activity of the new compounds on the full NCI human tumor cell line panel highlighted several compounds that are able to inhibit tumor cell proliferation at micromolar-submicromolar concentrations. The most active derivative 11g was found to cause

  通过通用且高产率的多步骤序列合成了一系列[1,3]噻唑并[4,5- e ]异吲哚。对新化合物在完整的NCI人肿瘤细胞系中的抗增殖活性的评估突出了几种能够在微摩尔-亚微摩尔浓度下抑制肿瘤细胞增殖的化合物。发现最活跃的衍生物11g沿着线粒体途径，导致细胞周期停滞在G2 / M期并诱导HeLa细胞凋亡，使其成为发现新抗有丝分裂药物的先导化合物。
• PYRIDYLPYRROLE COMPOUNDS USEFUL AS INTERLEUKIN-AND TNF ANTAGONISTS
  申请人：——

  公开号：US20020049235A1

  公开（公告）日：2002-04-25

  The present invention provides a compound of the formula: 1 and its pharmaceutically acceptable salts, wherein R 1 , R 2 , R 3 , R 4 , R 5 and m are as defined in claim 1. The present invention also provides processes for the preparation thereof, the use thereof in treating cytokines mediated diseases and/or cell adhesion molecules (CAMs) mediated diseases and pharmaceutical compositions for use in such therapy.

  本发明提供了一种符合以下公式的化合物：1及其药用可接受的盐，其中R1、R2、R3、R4、R5和m如权利要求1中定义的。本发明还提供了制备该化合物的方法，以及在治疗细胞因子介导的疾病和/或细胞粘附分子（CAMs）介导的疾病中使用该化合物的用途和用于该疗法的药物组合物。
• Synthesis of the new ring system 6,8-dihydro-5H-pyrrolo[3,4-h]quinazoline
  作者：Paola Barraja、Virginia Spanò、Patrizia Diana、Anna Carbone、Girolamo Cirrincione

  DOI：10.1016/j.tetlet.2009.07.045

  日期：2009.9

  A convenient synthesis of the pyrrolo[3,4-h]quinazoline ring system is reported. Our synthetic approach consisted of the annelation of a pyrimidine ring to an isoindole moiety using tetrahydroisoindole-4-ones as building blocks. The antiproliferative activity of the new compounds was investigated and one of them showed antitumor activity against all the 59 tested cell lines at micromolar concentrations

  报道了吡咯并[3，4- h ]喹唑啉环系统的方便合成。我们的合成方法包括使用四氢异吲哚-4-酮作为构建基，使嘧啶环与异吲哚部分成环。研究了新化合物的抗增殖活性，其中一种在微摩尔浓度（1.46-18.4μM）下显示了对所有59种测试细胞系的抗肿瘤活性。